首页> 美国卫生研究院文献>Arrhythmia Electrophysiology Review >Premature Ventricular Complex-induced Cardiomyopathy
【2h】

Premature Ventricular Complex-induced Cardiomyopathy

机译:室性早搏诱发的心肌病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Premature ventricular complex-induced cardiomyopathy is a potentially reversible condition in which left ventricular dysfunction is induced by the occurrence of frequent premature ventricular complexes (PVCs). Various cellular and extracellular mechanisms and risk factors for developing cardiomyopathy in this context have been suggested but the exact pathophysiological mechanism remains unclear. The suppression of PVCs is usually indicated in symptomatic patients with frequent PVCs and also those with left ventricular dysfunction. Antiarrhythmic drugs are a useful non-invasive treatment to eliminate PVCs, but the side effect profile, including the risk of pro-arrhythmia, along with suboptimal clinical effectiveness, should be weighed against the usually more effective but not risk-free treatment with catheter ablation. The latter has progressively become first line therapy in many patients with PVC-induced cardiomyopathy and should be particularly considered in specific scenarios.
机译:室性早搏诱发的心肌病是一种潜在的可逆性疾病,其中频繁发生的室性早搏复合物(PVC)引起左室功能障碍。在这种情况下,已经提出了多种细胞和细胞外机制以及发展为心肌病的危险因素,但是确切的病理生理机制仍不清楚。通常在症状频繁的PVC患者以及左心功能不全的有症状患者中可以抑制PVC。抗心律失常药物是消除PVC的有用的非侵入性治疗方法,但应权衡通常更有效但并非无风险的导管消融治疗的副作用,包括心律失常的风险以及临床效果欠佳。后者已逐渐成为许多PVC诱发的心肌病患者的一线治疗,在特定情况下应特别考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号